Ropivacaine Hydrochloride Injection
InfoRLife SA · Limited Availability · Reason: Other
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 03/27/2018
- Package NDC
- 25021-671-66
- Generic name
- Ropivacaine Hydrochloride Injection
- Contact info
- Sagent: 866-625-1618
- Availability
- Limited Availability
- Related info
- Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals
- Update date
- 08/18/2026
- Dosage form
- Injection
- Presentation
- Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)
- Company name
- InfoRLife SA
- Shortage reason
- Other
- Status
- Current
- Therapeutic category
- Anesthesia
- Harmonized identifiers (openFDA)
- Application number
- ANDA206166
- Brand name
- ROPIVACAINE HYDROCHLORIDE
- Generic name
- ROPIVACAINE HYDROCHLORIDE
- Manufacturer name
- Sagent Pharmaceuticals
- Product NDC
- 25021-671, 25021-652
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- EPIDURAL, INFILTRATION
- Substance name
- ROPIVACAINE HYDROCHLORIDE
- RxCUI
- 1734347, 1734355, 1734479, 1734481
- SPL ID
- 41f4446a-ca6e-465e-9a79-8c4f99eb1ac3, 22d83514-0f7b-4671-ae6a-7ca47449c184
- SPL set ID
- 8c5c762f-d266-4b1a-809e-f11bfc89bc2d, 9572b3de-684c-4028-a577-5aa69ba6b02d
- Package NDC
- 25021-671-82, 25021-671-87, 25021-652-82, 25021-652-87, 25021-671-66, 25021-671-67
- UNII
- V910P86109